NCT02380053View on ClinicalTrials.gov

Chronic Beta-blockade and Cardiopulmonary Exercise in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Bisoprolol

2 weeks of Bisoprolol 2.5mg daily then 2 weeks Bisoprolol 5mg daily

DRUG

Celiprolol

2 weeks of Celiprolol 200mg daily then 2 weeks Celiprolol 400mg daily

Trial Locations (1)

DD1 9SY

Asthma and Allergy Research Group, Ninewells Hospital and Medical School, University of Dundee, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT02380053 - Chronic Beta-blockade and Cardiopulmonary Exercise in COPD | Biotech Hunter | Biotech Hunter